Literature DB >> 15729869

Beta-mannosidosis with angiokeratoma corporis diffusum.

Nuiko Suzuki1, Izumi Konohana, Tomoko Fukushige, Tamotsu Kanzaki.   

Abstract

Beta-mannosidosis is a lysosomal disorder which is caused by a deficiency of beta-mannosidase. This disorder was first described in goats. Twelve human cases have already been reported. We present the first case in Japan in whom the diagnosis was reached from angiokeratoma corporis diffusum. Futhermore, mental retardation, hearing loss, and renal failure were also detected. Pseudoxanthoma elasticum was also present, but whether it is a complication of beta-mannosidosis or not remains unknown. The activity level of beta-mannosidase in the patient's plasma was only 2% of the normal range, while that in the patient's mother was 40%. We suggest that beta-mannosidosis should be one of the differential diagnoses when lysosomal enzyme disorders are suspected in cases of angiokeratoma corporis diffusum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15729869     DOI: 10.1111/j.1346-8138.2004.tb00630.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  A comparative structural bioinformatics analysis of inherited mutations in β-D-Mannosidase across multiple species reveals a genotype-phenotype correlation.

Authors:  Thi Huynh; Javed Mohammed Khan; Shoba Ranganathan
Journal:  BMC Genomics       Date:  2011-11-30       Impact factor: 3.969

2.  β-Mannosidosis caused by a novel homozygous intragenic inverted duplication in MANBA.

Authors:  Maria Blomqvist; Marie Falkenberg Smeland; Julia Lindgren; Per Sikora; Hilde Monica Frostad Riise Stensland; Jorge Asin-Cayuela
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-06-03

3.  Oral manifestation and dental treatment of pediatric patient with beta-mannosidosis: A case report.

Authors:  Mohammad A Alshoraim; Dania E Al Agili
Journal:  SAGE Open Med Case Rep       Date:  2021-12-15

4.  A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.

Authors:  Frédérique Sabourdy; Pierre Labauge; Hilde Monica Frostad Riise Stensland; Michèle Nieto; Violeta Latorre Garcés; Dimitri Renard; Giovanni Castelnovo; Nicolas de Champfleur; Thierry Levade
Journal:  BMC Med Genet       Date:  2009-09-03       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.